Literature DB >> 23689596

Ocular protection in facial paralysis.

Prabhat Bhama1, Amit D Bhrany.   

Abstract

PURPOSE OF REVIEW: Facial nerve paralysis has a profound impact on patients' quality of life, of which one of the most important sequelae is a risk of corneal surface disease. Herein, we discuss methods to protect the eye following insult to the facial nerve. RECENT
FINDINGS: Protection of the ocular surface in patients with facial nerve injury is of paramount importance to prevent corneal injury and potential blindness. Many interventions on the eye are temporary and therefore easily reversible. A systematic approach to managing the eye is required in these patients.
SUMMARY: This article provides a review of current methods used for ocular protection in patients with facial nerve paralysis.

Entities:  

Mesh:

Year:  2013        PMID: 23689596     DOI: 10.1097/MOO.0b013e32836239cf

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  4 in total

1.  Toward the Bionic Face: A Novel Neuroprosthetic Device Paradigm for Facial Reanimation Consisting of Neural Blockade and Functional Electrical Stimulation.

Authors:  Nate Jowett; Robert E Kearney; Christopher J Knox; Tessa A Hadlock
Journal:  Plast Reconstr Surg       Date:  2019-01       Impact factor: 4.730

2.  Use of steroids for facial nerve paralysis after parotidectomy: A systematic review.

Authors:  Kiran Varadharajan; Issa Beegun; Niall Daly
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

Review 3.  [Rehabilitation of facial palsy and vertigo in patients with vestibular schwannoma].

Authors:  B Müller; G F Volk; O Guntinas-Lichius
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

4.  Clinician and Automated Assessments of Facial Function Following Eyelid Weight Placement.

Authors:  Jacqueline J Greene; Joana Tavares; Diego L Guarin; Tessa Hadlock
Journal:  JAMA Facial Plast Surg       Date:  2019-09-01       Impact factor: 4.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.